-
Je něco špatně v tomto záznamu ?
Waiting Time for Second Kidney Transplantation and Mortality
A. Kainz, M. Kammer, R. Reindl-Schwaighofer, S. Strohmaier, V. Petr, O. Viklicky, D. Abramowicz, M. Naik, G. Mayer, R. Oberbauer
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2006 do Před 1 rokem
PubMed Central
od 2008 do Před 1 rokem
Europe PubMed Central
od 2008 do Před 1 rokem
Open Access Digital Library
od 2006-01-01
PubMed
34965955
DOI
10.2215/cjn.07620621
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- chronické selhání ledvin mortalita chirurgie MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- opakovaná terapie statistika a číselné údaje MeSH
- retrospektivní studie MeSH
- seznamy čekatelů * MeSH
- transplantace ledvin statistika a číselné údaje MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND AND OBJECTIVES: The median kidney transplant half-life is 10-15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer associated with a lower risk of mortality compared with waitlisted patients treated by dialysis. Therefore, we investigated the association of time on waiting list with patient survival in patients who received a second transplantation versus remaining on the waiting list. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective study using target trial emulation, we analyzed data of 2346 patients from the Austrian Dialysis and Transplant Registry and Eurotransplant with a failed first graft, aged over 18 years, and waitlisted for a second kidney transplantation in Austria during the years 1980-2019. The differences in restricted mean survival time and hazard ratios for all-cause mortality comparing the treatment strategies "retransplant" versus "remain waitlisted with maintenance dialysis" are reported for different waiting times after first graft loss. RESULTS: Second kidney transplantation showed a longer restricted mean survival time at 10 years of follow-up compared with remaining on the waiting list (5.8 life months gained; 95% confidence interval, 0.9 to 11.1). This survival difference was diminished in patients with longer waiting time after loss of the first allograft; restricted mean survival time differences at 10 years were 8.0 (95% confidence interval, 1.9 to 14.0) and 0.1 life months gained (95% confidence interval, -14.3 to 15.2) for patients with waiting time for retransplantation of <1 and 8 years, respectively. CONCLUSIONS: Second kidney transplant is associated with patient survival compared with remaining waitlisted and treatment by dialysis, but the survival difference diminishes with longer waiting time.
Austrian Dialysis and Transplant Registry Innsbruck Austria
Berlin Institute of Health Berlin Germany
Department of Epidemiology Medical University of Vienna Vienna Austria
Department of Nephrology and Medical Intensive Care Charité Universitätsmedizin Berlin Germany
Department of Nephrology Antwerp University Hospital Antwerp Belgium
Department of Nephrology Medical University of Vienna Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011438
- 003
- CZ-PrNML
- 005
- 20220506130619.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2215/CJN.07620621 $2 doi
- 035 __
- $a (PubMed)34965955
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kainz, Alexander $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/000000018888440X
- 245 10
- $a Waiting Time for Second Kidney Transplantation and Mortality / $c A. Kainz, M. Kammer, R. Reindl-Schwaighofer, S. Strohmaier, V. Petr, O. Viklicky, D. Abramowicz, M. Naik, G. Mayer, R. Oberbauer
- 520 9_
- $a BACKGROUND AND OBJECTIVES: The median kidney transplant half-life is 10-15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer associated with a lower risk of mortality compared with waitlisted patients treated by dialysis. Therefore, we investigated the association of time on waiting list with patient survival in patients who received a second transplantation versus remaining on the waiting list. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective study using target trial emulation, we analyzed data of 2346 patients from the Austrian Dialysis and Transplant Registry and Eurotransplant with a failed first graft, aged over 18 years, and waitlisted for a second kidney transplantation in Austria during the years 1980-2019. The differences in restricted mean survival time and hazard ratios for all-cause mortality comparing the treatment strategies "retransplant" versus "remain waitlisted with maintenance dialysis" are reported for different waiting times after first graft loss. RESULTS: Second kidney transplantation showed a longer restricted mean survival time at 10 years of follow-up compared with remaining on the waiting list (5.8 life months gained; 95% confidence interval, 0.9 to 11.1). This survival difference was diminished in patients with longer waiting time after loss of the first allograft; restricted mean survival time differences at 10 years were 8.0 (95% confidence interval, 1.9 to 14.0) and 0.1 life months gained (95% confidence interval, -14.3 to 15.2) for patients with waiting time for retransplantation of <1 and 8 years, respectively. CONCLUSIONS: Second kidney transplant is associated with patient survival compared with remaining waitlisted and treatment by dialysis, but the survival difference diminishes with longer waiting time.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronické selhání ledvin $x mortalita $x chirurgie $7 D007676
- 650 _2
- $a transplantace ledvin $x statistika a číselné údaje $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a opakovaná terapie $x statistika a číselné údaje $7 D019233
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a časové faktory $7 D013997
- 650 12
- $a seznamy čekatelů $7 D014850
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kammer, Michael $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $u Institute of Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Reindl-Schwaighofer, Roman $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000244196282
- 700 1_
- $a Strohmaier, Susanne $u Department of Epidemiology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Petr, Vojtěch $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Viklicky, Ondrej $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Abramowicz, Daniel $u Department of Nephrology, Antwerp University Hospital, Antwerp, Belgium $1 https://orcid.org/0000000265569199
- 700 1_
- $a Naik, Marcel $u Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin, Berlin, Germany $u Berlin Institute of Health, Berlin, Germany
- 700 1_
- $a Mayer, Gert $u Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria $u Austrian Dialysis and Transplant Registry, Innsbruck, Austria
- 700 1_
- $a Oberbauer, Rainer $u Department of Nephrology, Medical University of Vienna, Vienna, Austria rainer.oberbauer@meduniwien.ac.at
- 773 0_
- $w MED00156165 $t Clinical journal of the American Society of Nephrology : CJASN $x 1555-905X $g Roč. 17, č. 1 (2022), s. 90-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34965955 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130611 $b ABA008
- 999 __
- $a ok $b bmc $g 1789169 $s 1162636
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 17 $c 1 $d 90-97 $e 20211229 $i 1555-905X $m Clinical journal of the American Society of Nephrology $n Clin J Am Soc Nephrol $x MED00156165
- LZP __
- $a Pubmed-20220425